Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

NIPA Deficiency Leads To Acceleration Of The Lymphoma Development In EµMyc Mice

Anna Lena Illert, M.D, Cathrin Klingeberg, Corinna Albers, Ph.D, Stephan w. Morris, MD, PhD, Christian Peschel, Ulrich Keller, Justus Duyster

Blood (2013) 122 (21): 3681.

https://doi.org/10.1182/blood.V122.21.3681.3681

Published: 2013

Journal Articles

Identification Of a Novel Mode Of Kinase Inhibitor Resistance In JAK2: JAK2 Inhibitor Resistance Is Mediated By The Generation Of 45-Kda JAK2 Variant Which Alters The Kinase Domain Structure

Sivahari Prasad Gorantla, Ph.D, Nikolas von Bubnoff, M.D, Martina Rudelius, M.D, Corinna Albers, Ph.D, Anna Lena Illert, M.D, Heiko Becker, MD, Christian Peschel, Justus Duyster

Blood (2013) 122 (21): 113.

https://doi.org/10.1182/blood.V122.21.113.113

Published: 2013

Journal Articles

SRC is a signaling mediator in FLT3-ITD– but not in FLT3-TKD–positive AML

Hannes Leischner, Corinna Albers, Rebekka Grundler, Elena Razumovskaya, Karsten Spiekermann, Stefan Bohlander, Lars Rönnstrand, Katharina Götze, Christian Peschel, Justus Duyster

Blood (2012) 119 (17): 4026–4033.

https://doi.org/10.1182/blood-2011-07-365726

Published: 2012

Includes: Supplemental data

Journal Articles

The F-Box Protein NIPA Regulates the Hematopoietic Stem Cell Pool

Stefanie Kreutmair, Anna Lena Illert, MD, Rouzanna Istvanffy, PhD, Melanie Sickinger, Christina Eckl, Corinna Albers, PhD, Christian Peschel, MD, Robert A.J. Oostendorp, BSc, MSc, PhD, Justus Duyster, MD

Blood (2011) 118 (21): 2330.

https://doi.org/10.1182/blood.V118.21.2330.2330

Published: 2011

Journal Articles

An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL–driven leukemogenesis

Corinna Albers, Anna L. Illert, Cornelius Miething, Hannes Leischner, Melanie Thiede, Christian Peschel, Justus Duyster

Blood (2011) 118 (8): 2200–2210.

https://doi.org/10.1182/blood-2010-10-309583

Published: 2011

Includes: Supplemental data

Journal Articles

Combination of c-SRC and FLT3 Inhibitors Has An Additive Inhibitory Effect on FLT3 ITD but Not on FLT3 TKD Positive Cells

Hannes Leischner, Rebekka Grundler, Corinna Albers, Anna Lena Illert, MD, Katharina Götze, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2010) 116 (21): 2892.

https://doi.org/10.1182/blood.V116.21.2892.2892

Published: 2010

Journal Articles

NIPA Checkpoint Control In Oncogenic Transformation Is Dependent on p53

Anna Lena Illert, MD, Hiroyuki Kawaguchi, MD, PhD, Corinna Albers, PhD, Melanie Sickinger, Ulrich Keller, MD, Stephan w. Morris, MD, PhD, Christian Peschel, MD, Justus Duyster, MD

Blood (2010) 116 (21): 4178.

https://doi.org/10.1182/blood.V116.21.4178.4178

Published: 2010

Journal Articles

A Single Retroviral Vector Design for the Simultaneous Expression of a Mir30 Based Shrna with An Oncogene – Identification of Raf-1 but Not BRAF as a Crucial Mediator for BCR-ABL Mediated Leukemogenesis.

Corinna Albers, Anna Lena Illert, MD, Hannes Leischner, Cornelius Miething, MD, Richard Huss, Christian Peschel, MD, Justus Duyster, MD

Blood (2010) 116 (21): 3392.

https://doi.org/10.1182/blood.V116.21.3392.3392

Published: 2010

Journal Articles

SRC Is a Critical Signaling Mediator in FLT3-ITD Positive AML.

Hannes Leischner, Rebekka Grundler, Ph.D, Corinna Albers, Anna Lena Illert, Karsten Spiekermann, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2009) 114 (22): 477.

https://doi.org/10.1182/blood.V114.22.477.477

Published: 2009

Journal Articles

NIPA Phosphorylation and Inactivation at G2/M Is Mediated by ERK2.

Michael Zech, Anna Lena Illert, MD, Corinna Albers, Florian Bassermann, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2009) 114 (22): 2513.

https://doi.org/10.1182/blood.V114.22.2513.2513

Published: 2009

Journal Articles

Raf1 Is Required for Induction of a Bcr-Abl Positive CML Like Myeloproliferative Disease in Mice

Corinna Albers, Anna Lena Illert, MD, Cornelius Miething, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2008) 112 (11): 3207.

https://doi.org/10.1182/blood.V112.11.3207.3207

Published: 2008

Journal Articles

Grb10 Mediated Akt Activation Is Required for Induction of CML Like Myeloproliferative Disease in Mice by BCR-ABL.

Corinna Albers, Anna L. Illert, MD, Cornelius Miething, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2007) 110 (11): 1012.

https://doi.org/10.1182/blood.V110.11.1012.1012

Published: 2007

NARROW

NIPA Deficiency Leads To Acceleration Of The Lymphoma Development In EµMyc Mice

Identification Of a Novel Mode Of Kinase Inhibitor Resistance In JAK2: JAK2 Inhibitor Resistance Is Mediated By The Generation Of 45-Kda JAK2 Variant Which Alters The Kinase Domain Structure

SRC is a signaling mediator in FLT3-ITD– but not in FLT3-TKD–positive AML

The F-Box Protein NIPA Regulates the Hematopoietic Stem Cell Pool

An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL–driven leukemogenesis

Combination of c-SRC and FLT3 Inhibitors Has An Additive Inhibitory Effect on FLT3 ITD but Not on FLT3 TKD Positive Cells

NIPA Checkpoint Control In Oncogenic Transformation Is Dependent on p53

A Single Retroviral Vector Design for the Simultaneous Expression of a Mir30 Based Shrna with An Oncogene – Identification of Raf-1 but Not BRAF as a Crucial Mediator for BCR-ABL Mediated Leukemogenesis.

SRC Is a Critical Signaling Mediator in FLT3-ITD Positive AML.

NIPA Phosphorylation and Inactivation at G2/M Is Mediated by ERK2.

Raf1 Is Required for Induction of a Bcr-Abl Positive CML Like Myeloproliferative Disease in Mice

Grb10 Mediated Akt Activation Is Required for Induction of CML Like Myeloproliferative Disease in Mice by BCR-ABL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only